세계의 백신 보관 및 포장 시장 : 시장 규모, 점유율, 동향 분석 - 기능별, 지역별, 부문별 예측(2025-2030년)

Vaccine Storage And Packaging Market Growth & Trends:

The global vaccine storage and packaging market size is anticipated to reach USD 47.02 billion by 2030 and is anticipated to expand at a CAGR of 11.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Significant growth in demand for efficient storage and packaging services by manufacturers and the focus of government agencies on improving immunization coverage drive the market.

Multiple government agencies and international health organizations working across regions have focused on enhancing immunization coverage by ensuring vaccine availability, improved access, and effective distribution. This has significantly increased the demand for vaccine storage and packaging services across regions. The lack of sophisticated healthcare infrastructure has increased the requirements for packaging excellence.

Innovations, strategic advancements by key market participants, and the increasing focus of multiple companies on improving storage capacity to strengthen their market positions are creating lucrative growth opportunities. Immunization programs initiated by organizations such as the WHO and Gavi contribute to the growing market demand.

Vaccine Storage And Packaging Market Report Highlights:

• The storage segment dominated the vaccine storage and packaging market with more than 55 % revenue share, owing to the growing demand for efficient storage linked to immunization programs initiated by multiple governments.
• Storage services held a larger market share than storage equipment such as refrigerators, freezers, and accessories.
• Vaccine bags, vials, and ampoules accounted for the largest market share in packaging materials.
• North America dominated the global industry in 2024, owing to the presence of multiple vaccine manufacturers, a robust warehousing industry, and increasing demand driven by the involvement of international health organizations in immunization programs.
• In April 2025, DHL announced an investment of nearly USD 2.26 billion to enhance its logistics capacities in the life sciences and healthcare sectors.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Function
  • 1.2.2. Regional Scope
  • 1.2.3. Estimates and Forecasts Timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
  • 1.4.5. Details of Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type Outlook
  • 2.2.2. Management Outlook
  • 2.2.3. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Vaccine Storage and Packaging Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Vaccine Storage and Packaging Market Analysis tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrant
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTEL Analysis

Chapter 4. Vaccine Storage and Packaging Market: Function Estimates & Trend Analysis

• 4.1. Function Segment Dashboard
• 4.2. Vaccine Storage and Packaging Market: Function Movement Analysis
• 4.3. Global Vaccine Storage and Packaging Market Size & Trend Analysis, by Function, 2018 to 2030 (USD Million)
• 4.4. Storage
  • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Storage equipment
    • 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.2.2. Refrigerator
      • 4.4.2.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.2.3. Freezer
      • 4.4.2.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.2.4. Others (accessories)
      • 4.4.2.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Service
    • 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.3.2. Warehouse storage
      • 4.4.3.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.3.3. Transportation (Cold Retainers)
      • 4.4.3.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.5. Packaging
  • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5.2. Material
    • 4.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.2.2. Vaccine bags, vials, ampoules
      • 4.5.2.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.2.3. Corrugated boxes
      • 4.5.2.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.2.4. Others
      • 4.5.2.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Type
    • 4.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.3.2. Primary
      • 4.5.3.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.3.3. Secondary
      • 4.5.3.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.3.4. Tertiary
      • 4.5.3.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Vaccine Storage and Packaging Market: Regional Estimates & Trend Analysis

• 5.1. Regional Market Dashboard
• 5.2. Regional Market Share Analysis, 2024 & 2030
• 5.3. Continuous Bioprocessing Market By Region: Key Takeaways
• 5.4. North America
  • 5.4.1. U.S.
    • 5.4.1.1. Key Country Dynamics
    • 5.4.1.2. Regulatory Framework/ Reimbursement Structure
    • 5.4.1.3. Competitive Scenario
    • 5.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Canada
    • 5.4.2.1. Key Country Dynamics
    • 5.4.2.2. Regulatory Framework/ Reimbursement Structure
    • 5.4.2.3. Competitive Scenario
    • 5.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Mexico
    • 5.4.3.1. Key Country Dynamics
    • 5.4.3.2. Regulatory Framework/ Reimbursement Structure
    • 5.4.3.3. Competitive Scenario
    • 5.4.3.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.5. Europe
  • 5.5.1. UK
    • 5.5.1.1. Key Country Dynamics
    • 5.5.1.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.1.3. Competitive Scenario
    • 5.5.1.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.2. Germany
    • 5.5.2.1. Key Country Dynamics
    • 5.5.2.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.2.3. Competitive Scenario
    • 5.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.3. France
    • 5.5.3.1. Key Country Dynamics
    • 5.5.3.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.3.3. Competitive Scenario
    • 5.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.4. Italy
    • 5.5.4.1. Key Country Dynamics
    • 5.5.4.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.4.3. Competitive Scenario
    • 5.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.5. Spain
    • 5.5.5.1. Key Country Dynamics
    • 5.5.5.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.5.3. Competitive Scenario
    • 5.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.6. Denmark
    • 5.5.6.1. Key Country Dynamics
    • 5.5.6.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.6.3. Competitive Scenario
    • 5.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.7. Sweden
    • 5.5.7.1. Key Country Dynamics
    • 5.5.7.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.7.3. Competitive Scenario
    • 5.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.8. Norway
    • 5.5.8.1. Key Country Dynamics
    • 5.5.8.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.8.3. Competitive Scenario
    • 5.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.6. Asia Pacific
  • 5.6.1. Japan
    • 5.6.1.1. Key Country Dynamics
    • 5.6.1.2. Regulatory Framework/ Reimbursement Structure
    • 5.6.1.3. Competitive Scenario
    • 5.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6.2. China
    • 5.6.2.1. Key Country Dynamics
    • 5.6.2.2. Regulatory Framework/ Reimbursement Structure
    • 5.6.2.3. Competitive Scenario
    • 5.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6.3. India
    • 5.6.3.1. Key Country Dynamics
    • 5.6.3.2. Regulatory Framework/ Reimbursement Structure
    • 5.6.3.3. Competitive Scenario
    • 5.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6.4. South Korea
    • 5.6.4.1. Key Country Dynamics
    • 5.6.4.2. Regulatory Framework/ Reimbursement Structure
    • 5.6.4.3. Competitive Scenario
    • 5.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6.5. Thailand
    • 5.6.5.1. Key Country Dynamics
    • 5.6.5.2. Regulatory Framework/ Reimbursement Structure
    • 5.6.5.3. Competitive Scenario
    • 5.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6.6. Australia
    • 5.6.6.1. Key Country Dynamics
    • 5.6.6.2. Regulatory Framework/ Reimbursement Structure
    • 5.6.6.3. Competitive Scenario
    • 5.6.6.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.7. Latin America
  • 5.7.1. Brazil
    • 5.7.1.1. Key Country Dynamics
    • 5.7.1.2. Regulatory Framework/ Reimbursement Structure
    • 5.7.1.3. Competitive Scenario
    • 5.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7.2. Argentina
    • 5.7.2.1. Key Country Dynamics
    • 5.7.2.2. Regulatory Framework/ Reimbursement Structure
    • 5.7.2.3. Competitive Scenario
    • 5.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7.3. Columbia
    • 5.7.3.1. Key Country Dynamics
    • 5.7.3.2. Regulatory Framework/ Reimbursement Structure
    • 5.7.3.3. Competitive Scenario
    • 5.7.3.4. Columbia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7.4. Chile
    • 5.7.4.1. Key Country Dynamics
    • 5.7.4.2. Regulatory Framework/ Reimbursement Structure
    • 5.7.4.3. Competitive Scenario
    • 5.7.4.4. Chile Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.8. MEA
  • 5.8.1. South Africa
    • 5.8.1.1. Key Country Dynamics
    • 5.8.1.2. Regulatory Framework/ Reimbursement Structure
    • 5.8.1.3. Competitive Scenario
    • 5.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8.2. Saudi Arabia
    • 5.8.2.1. Key Country Dynamics
    • 5.8.2.2. Regulatory Framework/ Reimbursement Structure
    • 5.8.2.3. Competitive Scenario
    • 5.8.2.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8.3. UAE
    • 5.8.3.1. Key Country Dynamics
    • 5.8.3.2. Regulatory Framework/ Reimbursement Structure
    • 5.8.3.3. Competitive Scenario
    • 5.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8.4. Israel
    • 5.8.4.1. Key Country Dynamics
    • 5.8.4.2. Regulatory Framework/ Reimbursement Structure
    • 5.8.4.3. Competitive Scenario
    • 5.8.4.4. Israel Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8.5. Kuwait
    • 5.8.5.1. Key Country Dynamics
    • 5.8.5.2. Regulatory Framework/ Reimbursement Structure
    • 5.8.5.3. Competitive Scenario
    • 5.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
• 6.3. Vendor Landscape
  • 6.3.1. Key Company Heat Map Analysis, 2024
• 6.4. Company Profiles
  • 6.4.1. Lineage, Inc.
    • 6.4.1.1. Company Overview
    • 6.4.1.2. Financial Performance
    • 6.4.1.3. Product Benchmarking
    • 6.4.1.4. Strategic Initiatives
  • 6.4.2. AmerisourceBergen Corporation
    • 6.4.2.1. Company Overview
    • 6.4.2.2. Financial Performance
    • 6.4.2.3. Product Benchmarking
    • 6.4.2.4. Strategic Initiatives
  • 6.4.3. DHL
    • 6.4.3.1. Company Overview
    • 6.4.3.2. Financial Performance
    • 6.4.3.3. Product Benchmarking
    • 6.4.3.4. Strategic Initiatives
  • 6.4.4. DB SCHENKER
    • 6.4.4.1. Company Overview
    • 6.4.4.2. Financial Performance
    • 6.4.4.3. Product Benchmarking
    • 6.4.4.4. Strategic Initiatives
  • 6.4.5. CARDINAL LOGISTICS
    • 6.4.5.1. Company Overview
    • 6.4.5.2. Financial Performance
    • 6.4.5.3. Product Benchmarking
    • 6.4.5.4. Strategic Initiatives
  • 6.4.6. MCKESSON CORPORATION
    • 6.4.6.1. Company Overview
    • 6.4.6.2. Financial Performance
    • 6.4.6.3. Product Benchmarking
    • 6.4.6.4. Strategic Initiatives
  • 6.4.7. Thermo Fisher Scientific Inc.
    • 6.4.7.1. Company Overview
    • 6.4.7.2. Financial Performance
    • 6.4.7.3. Product Benchmarking
    • 6.4.7.4. Strategic Initiatives
  • 6.4.8. PHCbi (PANASONIC HEALTHCARE CO., LTD)
    • 6.4.8.1. Company Overview
    • 6.4.8.2. Financial Performance
    • 6.4.8.3. Product Benchmarking
    • 6.4.8.4. Strategic Initiatives
  • 6.4.9. American Biotech Supply
    • 6.4.9.1. Company Overview
    • 6.4.9.2. Financial Performance
    • 6.4.9.3. Product Benchmarking
    • 6.4.9.4. Strategic Initiatives
  • 6.4.10. Arctiko
    • 6.4.10.1. Company Overview
    • 6.4.10.2. Financial Performance
    • 6.4.10.3. Product Benchmarking
    • 6.4.10.4. Strategic Initiatives
  • 6.4.11. NIPRO
    • 6.4.11.1. Company Overview
    • 6.4.11.2. Financial Performance
    • 6.4.11.3. Product Benchmarking
    • 6.4.11.4. Strategic Initiatives